Personal Details Name: Homayoun Zargar Shoshtari DOB: 5 April 1976 Contact Number: +61 497 525 876 Email: [email protected] Website: homizargar.com.au Address: 176 Cotham road, Kew, Vic 3101
Work Experience
Consultant Urologist
PGY14 (July2016-July 2018): Uro-Oncology and Robotic Surgeon, Royal Melbourne Hospital, Australian Prostate Cancer Centre and Epworth Richmond Hospital
Fellowship Training PGY13 (July2015-July 2016): Melbourne Uro-Oncology Training Program (MUTP) Fellowship, Royal Melbourne Hospital/Peter MacCallum Cancer Centre PGY11 (July2013-July2015): Advanced Laparoscopic and Robotic Fellowship, Cleveland Clinic PGY10 (July2012-July2013): Uro-Oncology Fellowship University of British Colombia/Vancouver Prostate Centre
1 Specialist training PGY9 (Jan2011-Jan2012): SET V Urology, Auckland Public Hospital, Auckland PGY8 (Jan2010-Jan 2011): SET IV Urology, Waikato Hospital, Hamilton PGY7 (Dec2008-Jan2010): SET III Urology, Palmerston North Hospital, Palmerston North PGY6 (Dec2007-Dec2008): SET III general surgery, Christchurch Hospital, Christchurch PGY5 (Dec2006-Dec2007): SET II general surgery, Hutt Hospital, Wellington PGY4 (Dec2005-Dec2006): Basic trainee general surgery, Middlemore Hospital, Auckland PGY3 (June2005-Dec2005): Basic trainee urology, Auckland public Hospital, Auckland PGY3 (Dec2004-June2005): Basic trainee general surgery, North Shore Hospital, Auckland PGY2 (June2004-Dec2004): Basic trainee general surgery, Middlemore Hospital, Auckland PGY2 (Dec2003-June2004):House officer, Middlemore Hospital, Auckland PGY1 (Dec2002-Dec2003): House officer, Middlemore Hospital, Auckland
Qualifications
AHPRA Specialist Registration 2015 Society of Endourology Fellowship 2015 FRACS (Urol) August 2013 ECFMG Certificate Sep 2012 MBCHB Otago University Dec 2002
Academic Positions
Editorial Board Memberships
World Journal of Urology Editorial Board Minerva Nrologica e nefrologica Section Editor BMC Urology Associate Editor SRL Urology Associate Editor SM Journal of Urology Section Editor The Manual Editorial Board
Other Kidney Health Australia advisory board for kidney cancer
Teaching
Honorary Senior Clinical Lecturer, The University of Melbourne
2 Australian and New Zealand Surgical Skills Education and Training (ASSET) faculty member and instructor Honorary Clinical Lecturer in Surgery, Christchurch School of Medicine 2008 Honorary Clinical lecturer in Surgery, Wellington School of Medicine 2007
Reviewer for
European Urology Surgical Innovation Journal of Urology Australia and New Zealand Journal World Journal of Urology of Surgery European Urology Focus European Medical Journal-Urology Journal of Endourology International Journal of Urology Urology “GOLD JOURNAL” The Scientific World Journal Urology Oncology Journal Journal of genitourinary cancer
Society memberships
Fellow, Royal Australasian College of Surgeons Urological Society of Australia and New Zealand European Association of Urology American Urological Association Société Internationale d'Urologie ANZUP Cancer Trials Group
Awards and Grants
Top 1% reviewer for the most pre-publication peer reviews in medicine in 2017. Epworth research Institute 2016 Experienced Researcher Poster Award. The impact of United States preventive services task force (USPTSTF) recommendation on PSA testing in Australia. European Urology reviewer of the month. June 2016 Best poster in the session: Validation of the novel 5-group Gleason grading system: 3+5 disease risk may be overestimated. EAU 2016 Munich, Germany AUA Annual Audio-Visual Award, Honourable Mention. Perineal Robot Assisted Laparoscopic Radical Prostatectomy (P-Ralp). AUA 2015 New Orleans, LA AUA Annual Audio-Visual Award, Honourable Mention. Management Of Challenging Urethro-Ileal Anastomosis During Robotic Intracorporeal Neobladder Formation .AUA 2015 New Orleans, LA Best poster in the session: Final pathologic stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Does pT0 predict better survival than pTa/pTis/pT1?.EAU 2015 Madrid, Spain
3 Best poster in the session: The interval between diagnosis and radical cystectomy does not impact the outcomes of patients treated with neoadjuvant chemotherapy. EAU 2015 Madrid, Spain Canadian Urology Oncology Group (CUOG) Astellas grant recipient 2013 USANZ Wolf prize for the best trainee presentation 2010 Midcentral district health board supreme health award 2009 University of Otago distinction in General Practice 2002 University of Otago distinction in Medicine 2002 University of Otago RNZCGP Otago/Southland JAD Iverach prize in General Practice 2002 University of Otago Marjorie McCallum medal in Medicine 2002 University of Otago Iverach prize in Clinical Medicine 2002 The Otago Medical Research Foundation Research Scholarship 2001 University of Otago distinction in Medical practice 2001 University of Otago T.H Pullar memorial prize in Pathology 2001 University of Otago award in Medicine 1999
Book Chapters
Zargar H, Costello AJ (2018), Genitourinary Oncology, Textbook of Surgery 4th edition (in press)
Sharma P., Zargar-Shoshtari K., Zargar H., Spiess P.E. (2017) Pelvic Lymph Node Dissection for Penile Cancer: Answering the Conundrum of When and How It Should Be Conducted. In: Spiess P. (eds) Penile Cancer. Current Clinical Urology. Humana Press, New York, NY
Krishnan J., Zargar H., Kaouk J. (2017) Renal Reconstruction Techniques for Renal Tumors in Various Locations. In: Rané A., Turna B., Autorino R., Rassweiler J. (eds) Practical Tips in Urology. Springer, London
Brown R.D., Akca O., Zargar H., Stein R.J. (2017) LESS Ileal Interposition. In: Kaouk J., Stein R., Haber GP. (eds) Atlas of Laparoscopic and Robotic Single Site Surgery. Current Clinical Urology. Humana Press, New York, NY
Peer reviewed published articles Online access at http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1Bgc5csAjlx9lRqwjDmc9l5 AN/?sort=date&direction=ascending
1. Vasdev N, Zargar H, Noël JP, Veeratterapillay R, Fairey AS, et al. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with
4 neoadjuvant or induction chemotherapy followed by radical cystectomy. World J Urol. 2018 Jun 7;PubMed PMID: 29882105. 2. Nair R, Porpiglia F, Zargar H. Re: MRI-targeted or Standard Biopsy for Prostate- cancer Diagnosis. Eur Urol. 2018 Jun 6;PubMed PMID: 29886028. 3. Zargar H, Shah JB, van Rhijn BW, Daneshmand S, Bivalacqua TJ, et al. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy. J Urol. 2018 Jun;199(6):1452- 1458. PubMed PMID: 29329894. 4. Merrett C, Mannas M, Black PC, Zargar H. Magnet Before the Needle Commentary on: MRI-targeted or Standard Biopsy for Prostate-cancer Diagnosis (PRECISION Trial). Urology. 2018 May 3;PubMed PMID: 29730255. 5. Merrett C, Gross T, Moran D, Zargar H. Local recurrence of prostatic ductal adenocarcinoma despite clear surgical margins. Urol Case Rep. 2018 Mar;17:65-66. PubMed PMID: 29552497; PubMed Central PMCID: PMC5850878. 6. Malkoç E, Maurice MJ, Akça O, Kara Ö, Zargar H, et al. Significance of the nonneoplastic renal parenchymal findings in robotic partial nephrectomy series. J Nephrol. 2018 Feb 16;PubMed PMID: 29453652. 7. Chow K, Zargar H, Corcoran NM, Costello AJ, Peters JS, et al. Robotic-assisted radical cystectomy with intracorporeal urinary diversion versus open: early Australian experience. ANZ J Surg. 2018 Jan 8;PubMed PMID: 29316106. 8. Bertolo RG, Zargar H, Autorino R, Fiori C, Kaouk JH, et al. Estimated glomerular filtration rate, renal scan and volumetric assessment of the kidney before and after partial nephrectomy: a review of the current literature. Minerva Urol Nefrol. 2017 Dec;69(6):539-547. PubMed PMID: 28651424. 9. Zargar H, Shah JB, van de Putte EEF, Potvin KR, Zargar-Shoshtari K, et al. Dose dense MVAC prior to radical cystectomy: a real-world experience. World J Urol. 2017 Nov;35(11):1729-1736. PubMed PMID: 28625005. 10. Jo JK, Hong SK, Byun SS, Zargar H, Autorino R, et al. Positive surgical margin in robot-assisted radical prostatectomy: correlation with pathology findings and risk of biochemical recurrence. Minerva Urol Nefrol. 2017 Oct;69(5):493-500. PubMed PMID: 28376606. 11. Porpiglia F, Autorino R, Fiori C, Zargar H, Amparore D, et al. The impact of T1 renal tumor characteristics on baseline renal function in patients undergoing partial nephrectomy: A renal scan based objective assessment. Eur J Surg Oncol. 2017 Aug;43(8):1598-1602. PubMed PMID: 28579358. 12. van den Bergh RC, Zargar H, Heijmink S, Bozin M, Murphy DG, et al. Reducing the rate of biopsy Gleason undergrading may not improve biochemical recurrence rates in active surveillance candidates. Minerva Urol Nefrol. 2017 Aug;69(4):359-365. PubMed PMID: 28124869.
5 13. Kovac E, Firoozbakhsh F, Zargar H, Fergany A, Elsharkawy H. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review. Can J Anaesth. 2017 Jul;64(7):754-762. PubMed PMID: 28417354. 14. Nair R, Zargar-Shoshtari K, Zargar H. Bridging the gap: use of scaffolding tissue bio- grafts to bolster vesicourethral anastomosis during salvage robot-assisted prostatectomy reduced leak rates and catheter times. Transl Androl Urol. 2017 Jun;6(3):595-596. PubMed PMID: 28725605; PubMed Central PMCID: PMC5503971. 15. Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, et al. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017 Apr;71(4):606- 617. PubMed PMID: 27614693. 16. Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, et al. Use of the Satinsky clamp for hilar clamping during robotic partial nephrectomy: indications, technique, and multi-center outcomes. J Robot Surg. 2017 Mar;11(1):47-51. PubMed PMID: 27329237. 17. Andrade HS, Zargar H, Akca O, Kara O, Caputo PA, et al. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center. J Endourol. 2017 Feb;31(2):153-157. PubMed PMID: 27881027. 18. Pavan N, Derweesh I, Rassweiler J, Challacombe B, Zargar H, et al. Contemporary minimally invasive surgery for adrenal masses: it's not all about (pure) laparoscopy. BJU Int. 2017 Feb;119(2):201-203. PubMed PMID: 27801536. 19. Zargar H, Lamb AD, Rocco B, Porpiglia F, Liatsikos E, et al. Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis. Minerva Urol Nefrol. 2017 Feb;69(1):26-37. PubMed PMID: 27579821. 20. Lamb AD, Zargar H, Murphy DG, Corcoran NM, Hovens CM. Disrupting the Status Quo in Prostate Cancer Diagnosis. Eur Urol. 2017 Feb;71(2):193-194. PubMed PMID: 27554242. 21. Zargar H, Akca O, Caputo P, Ramirez D, Kara O, et al. Assessing the effects of modality of surgery on postoperative weight loss in patients undergoing partial nephrectomy. World J Urol. 2017 Feb;35(2):271-275. PubMed PMID: 27272313. 22. Zargar H, Almassi N, Kovac E, Ercole C, Remer E, et al. Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. Bladder Cancer. 2017 Jan 27;3(1):57-63. PubMed PMID: 28149936; PubMed Central PMCID: PMC5271424. 23. Mohsin M, Zargar HR, Wani AH, Zaroo MI, Baba PUF, et al. Role of customised negative-pressure wound therapy in the integration of split-thickness skin grafts: A randomised control study. Indian J Plast Surg. 2017 Jan-Apr;50(1):43-49. PubMed PMID: 28615809; PubMed Central PMCID: PMC5469234.
6 24. Sapre N, Zargar H. Urologic surgery laparoscopic access: vascular complications. Int Braz J Urol. 2017 Jan-Feb;43(1):167. PubMed PMID: 28124542; PubMed Central PMCID: PMC5293400. 25. Zargar-Shoshtari K, Lawrentschuk N, Zargar H. Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery: Commentary on: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study. Urology. 2017 Jan;99:3-4. PubMed PMID: 27720969. 26. Zargar-Shoshtari K, Murphy DG, Zargar H. Re: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study. Eur Urol. 2017 Jan;71(1):140-141. PubMed PMID: 27641790. 27. Zargar H, van den Bergh R, Moon D, Lawrentschuk N, Costello A, et al. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia. BJU Int. 2017 Jan;119(1):110-115. PubMed PMID: 27454454. 28. Caputo PA, Zargar H, Ramirez D, Andrade HS, Akca O, et al. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis. Eur Urol. 2017 Jan;71(1):111-117. PubMed PMID: 27568064. 29. Brandao LF, Laydner H, Akca O, Autorino R, Zargar H, et al. Robot-assisted ureteral reconstruction using a tubularized peritoneal flap: a novel technique in a chronic porcine model. World J Urol. 2017 Jan;35(1):89-96. PubMed PMID: 27151276. 30. Sharma P, Zargar H, Spiess PE. Surgical Advances in Inguinal Lymph Node Dissection: Optimizing Treatment Outcomes. Urol Clin North Am. 2016 Nov;43(4):457-468. PubMed PMID: 27717432. 31. van den Bergh RC, van der Kwast TH, de Jong J, Zargar H, Ryan AJ, et al. Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated. BJU Int. 2016 Oct;118(4):502-5. PubMed PMID: 26972452. 32. Andrade HS, Kaouk JH, Zargar H, Caputo PA, Akca O, et al. Robotic Ureteroureterostomy for Treatment of a Proximal Ureteric Stricture. Int Braz J Urol. 2016 Sep-Oct;42(5):1041-1042. PubMed PMID: 27763738; PubMed Central PMCID: PMC5066905. 33. Bozin M, Zargar H. Editorial Comment: Off-clamp robotic-assisted partial nephrectomy. Int Braz J Urol. 2016 Sep-Oct;42(5):1046. PubMed PMID: 27763741; PubMed Central PMCID: PMC5066908. 34. Jo JK, Hong SK, Byun SS, Zargar H, Autorino R, et al. Urinary Continence after Robot-Assisted Laparoscopic Radical Prostatectomy: The Impact of Intravesical Prostatic Protrusion. Yonsei Med J. 2016 Sep;57(5):1145-51. PubMed PMID: 27401645; PubMed Central PMCID: PMC4960380.
7 35. Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, et al. Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery. BJU Int. 2016 Aug;118(2):298-301. PubMed PMID: 27417163. 36. Akca O, Zargar H, Albayrak S, Kaouk JH. Author Reply. Urology. 2016 Aug;94:137- 8. PubMed PMID: 27370778. 37. Kaouk JH, Akca O, Zargar H, Caputo P, Ramirez D, et al. Descriptive Technique and Initial Results for Robotic Radical Perineal Prostatectomy. Urology. 2016 Aug;94:129-38. PubMed PMID: 27233935. 38. Kara O, Maurice MJ, Zargar H, Malkoc E, Akca O, et al. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma. Int Urol Nephrol. 2016 Aug;48(8):1253-60. PubMed PMID: 27215555. 39. Nyame YA, Zargar H, Ramirez D, Ganesan V, Babbar P, et al. Robotic-assisted Laparoscopic Bilateral Nerve Sparing and Apex Preserving Cystoprostatectomy in Young Men With Bladder Cancer. Urology. 2016 Aug;94:259-64. PubMed PMID: 27132504. 40. Vlok J, Zargar H. Editorial Comment: Two-Part Silicone Mold A New Tool For Flexible Ureteroscopy Surgical Training. Int Braz J Urol. 2016 Jul-Aug;42(4):852. PubMed PMID: 27564303; PubMed Central PMCID: PMC5006788. 41. Vyas R, Thompson CL, Zargar H, Selph J, Gerstenblith MR. Epidemiology of genitourinary melanoma in the United States: 1992 through 2012. J Am Acad Dermatol. 2016 Jul;75(1):144-50. PubMed PMID: 27317515. 42. Zargar H, Porpiglia F, Porter J, Quarto G, Perdona S, et al. Achievement of trifecta in minimally invasive partial nephrectomy correlates with functional preservation of operated kidney: a multi-institutional assessment using MAG3 renal scan. World J Urol. 2016 Jul;34(7):925-31. PubMed PMID: 26546072. 43. Andrade HS, Zargar H, Caputo PA, Akca O, Kara O, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol. 2016 Jun;69(6):1149-54. PubMed PMID: 26719014. 44. Autorino R, Zargar H, Akca O, Laydner H, Brandao LF, et al. Robot-assisted laparoendoscopic single-site inguinal lymphadenectomy: initial investigation in a cadaver model. Minerva Urol Nefrol. 2016 Jun;68(3):311-4. PubMed PMID: 26364569. 45. van den Bergh RC, Zargar H, Murphy DG. Re: Pathologic Outcomes in Favorable- risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol. 2016 May;69(5):964-5. PubMed PMID: 27301991. 46. Andrade HS, Zargar H, Caputo PA, Akca O, Ramirez D, et al. Robotic pyelolithotomy for staghorn nephrolithiasis during partial nephrectomy. Int Braz J Urol. 2016 May-Jun;42(3):623-5. PubMed PMID: 27286131; PubMed Central PMCID: PMC4920585.
8 47. Pavan N, Zargar H, Sanchez-Salas R, Castillo O, Celia A, et al. Robot-assisted Versus Standard Laparoscopy for Simple Prostatectomy: Multicenter Comparative Outcomes. Urology. 2016 May;91:104-10. PubMed PMID: 26948530. 48. Kara O, Zargar H, Akca O, Andrade HS, Caputo P, et al. Risks and Benefits of Pharmacological Prophylaxis for Venous Thromboembolism Prevention in Patients Undergoing Robotic Partial Nephrectomy. J Urol. 2016 May;195(5):1348-53. PubMed PMID: 26626222. 49. Zargar-Shoshtari K, Zargar H, Dinney CP, Ercole CE, Sharma P, et al. Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node- negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy. World J Urol. 2016 May;34(5):695-701. PubMed PMID: 26286880. 50. De S, Autorino R, Kim FJ, Zargar H, Laydner H, et al. Corrigendum re: "Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery: A Systematic Review and Meta-analysis" [Eur Urol 2015;67:125-37]. Eur Urol. 2016 Apr;69(4):e85. PubMed PMID: 27301798. 51. Zargar H, Zargar-Shoshtari K, Dundee P, Black PC. Predicting occult lymph node- positive disease at the time of radical cystectomy: a systematic review. Minerva Urol Nefrol. 2016 Apr;68(2):112-24. PubMed PMID: 26928572. 52. Zargar H, Zargar-Shoshtari K, Lotan Y, Shah JB, van Rhijn BW, et al. Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?. J Urol. 2016 Apr;195(4 Pt 1):886-93. PubMed PMID: 26521718. 53. Andrade HS, Zargar H, Akca O, Caputo PA, Ramirez D, et al. Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match- Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm. J Endourol. 2016 Apr;30(4):379-83. PubMed PMID: 26486995. 54. Almassi N, Zargar H, Ganesan V, Fergany A, Haber GP. Management of Challenging Urethro-ileal Anastomosis During Robotic Assisted Radical Cystectomy with Intracorporeal Neobladder Formation. Eur Urol. 2016 Apr;69(4):704-709. PubMed PMID: 26463317. 55. Murphy DG, Zargar H. Words of Wisdom Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. Eur Urol. 2016 Mar;69(3):540. PubMed PMID: 26867727. 56. Kara O, Andrade HS, Zargar H, Akca O, Maurice MJ, et al. Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center. J Robot Surg. 2016 Mar;10(1):5-10. PubMed PMID: 26861450.
9 57. Kara O, Akca O, Zargar H, Andrade HS, Maurice MJ, et al. Robotic Partial Nephrectomy in the Treatment of Renal Angiomyolipoma. J Endourol. 2016 Mar;30(3):275-9. PubMed PMID: 26654096. 58. Ramirez D, Caputo PA, Krishnan J, Zargar H, Kaouk JH. Robot-assisted partial nephrectomy with intracorporeal renal hypothermia using ice slush: step-by-step technique and matched comparison with warm ischaemia. BJU Int. 2016 Mar;117(3):531-6. PubMed PMID: 26435486. 59. Potretzke AM, Knight BA, Zargar H, Kaouk JH, Barod R, et al. Urinary fistula after robot-assisted partial nephrectomy: a multicentre analysis of 1 791 patients. BJU Int. 2016 Jan;117(1):131-7. PubMed PMID: 26235802. 60. Zargar-Shoshtari K, Zargar H, Lotan Y, Shah JB, van Rhijn BW, et al. A Multi- Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy. J Urol. 2016 Jan;195(1):53-9. PubMed PMID: 26205531. 61. Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, et al. Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol. 2016 Jan;69(1):116-28. PubMed PMID: 25819723. 62. Abdullah N, Dalela D, Barod R, Larson J, Johnson M, et al. Robotic partial nephrectomy for renal tumours in obese patients: Perioperative outcomes in a multi- institutional analysis. Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E859-62. PubMed PMID: 26788235; PubMed Central PMCID: PMC4707905. 63. Ramirez D, Zargar H, Caputo P, Kaouk JH. Robotic-assisted laparoscopic prostatectomy: An update on functional and oncologic outcomes, techniques, and advancements in technology. J Surg Oncol. 2015 Dec;112(7):746-52. PubMed PMID: 26369794. 64. Zargar H, Zargar-Shoshtari K, Laydner H, Autorino R. Anatomy of Contemporary Partial Nephrectomy: A Dissection of the Available Evidence. Eur Urol. 2015 Dec;68(6):993-5. PubMed PMID: 25964176. 65. Zargar H, Isac W, Autorino R, Khalifeh A, Nemer O, et al. Robot-assisted laparoscopic partial nephrectomy in patients with previous abdominal surgery: single center experience. Int J Med Robot. 2015 Dec;11(4):389-94. PubMed PMID: 25600756. 66. Zargar-Shoshtari K, Sharma P, Zargar H. Re: Medical Expulsive Therapy in Adults with Ureteric Colic: A Multicentre, Randomised, Placebo-controlled Trial. Eur Urol. 2015 Nov;68(5):910-1. PubMed PMID: 26460878. 67. Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, et al. Laparoscopic Cryoablation for Renal Cell Carcinoma: 100-Month Oncologic Outcomes. J Urol. 2015 Oct;194(4):892-6. PubMed PMID: 25912493.
10 68. Zargar H, Autorino R, Akca O, Brandao LF, Laydner H, et al. Minimally invasive partial nephrectomy in the age of the 'trifecta'. BJU Int. 2015 Oct;116(4):505-6. PubMed PMID: 25901967. 69. Zargar H, Giannarini G, Loeb S, Dasgupta P, Murphy DG, et al. Active surveillance in prostate cancer: a critical review. Minerva Urol Nefrol. 2015 Sep;67(3):247-61. PubMed PMID: 26054412. 70. Zargar H, Allaf ME, Bhayani S, Stifelman M, Rogers C, et al. Trifecta and optimal perioperative outcomes of robotic and laparoscopic partial nephrectomy in surgical treatment of small renal masses: a multi-institutional study. BJU Int. 2015 Sep;116(3):407-14. PubMed PMID: 25220543. 71. Akca O, Zargar H, Kaouk JH. Robotic Surgery Revives Radical Perineal Prostatectomy. Eur Urol. 2015 Aug;68(2):340-1. PubMed PMID: 25813693. 72. Brandao LF, Laydner H, Zargar H, Torricelli F, Andreoni C, et al. Laparoendoscopic single site surgery versus conventional laparoscopy for transperitoneal pyeloplasty: A systematic review and meta-analysis. Urol Ann. 2015 Jul-Sep;7(3):289-96. PubMed PMID: 26229312; PubMed Central PMCID: PMC4518361. 73. Mir MC, Zargar H, Bolton DM, Murphy DG, Lawrentschuk N. Enhanced Recovery After Surgery protocols for radical cystectomy surgery: review of current evidence and local protocols. ANZ J Surg. 2015 Jul-Aug;85(7-8):514-20. PubMed PMID: 25781409. 74. Autorino R, Zargar H, Porpiglia F. Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Riccardo Autorino, Homayoun Zagar, Mirandolino B Mariano, et al Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis Eur Urol 2015;68:86-94; Re: Matthew Bultitude, Ben Challacombe Simple Prostatectomy: A Step Too Far for Laparoscopy? Eur Urol 2015;68:95-6 Eur Urol 2015;68:e7-8. Eur Urol. 2015 Jul;68(1):e9-10. PubMed PMID: 25666848. 75. Akca O, Zargar H, Attalla K, Brandao LF, Laydner H, et al. Possible Detrimental Effects of Clamping Main Versus Segmental Renal Arteries for the Achievement of Renal Global Ischemia During Robot-Assisted Partial Nephrectomy. J Endourol. 2015 Jul;29(7):785-90. PubMed PMID: 25621894. 76. Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, et al. Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European- American Multi-institutional Analysis. Eur Urol. 2015 Jul;68(1):86-94. PubMed PMID: 25484140. 77. Akça O, Zargar H, Autorino R, Brandao LF, Gürler AS, et al. The transrectal single port laparoscopic radical prostatectomy in a cadaver model. Turk J Urol. 2015 Jun;41(2):78-82. PubMed PMID: 26328206; PubMed Central PMCID: PMC4548668.
11 78. Akca O, Kaouk JH, Zargar H, Brandao LF, Haber GP, et al. Robot assisted heminephrectomy for duplicated renal collecting system: technique and outcomes. Int J Med Robot. 2015 Jun;11(2):126-9. PubMed PMID: 25181680. 79. Zargar H, Marshall D, Siva G, King Q. Topical diltiazem before transrectal ultrasonography-guided biopsy of the prostate: a randomized controlled trial. ANZ J Surg. 2015 Jun;85(6):430-2. PubMed PMID: 24237929. 80. Mishra K, Zargar H, Tarplin S, Ramanathan R, Stein RJ. Idiopathic retroperitoneal fibrosis. J Urol. 2015 May;193(5):1657-8. PubMed PMID: 25659660. 81. Zargar H, Akca O, Autorino R, Brandao LF, Laydner H, et al. Ipsilateral renal function preservation after robot-assisted partial nephrectomy (RAPN): an objective analysis using mercapto-acetyltriglycine (MAG3) renal scan data and volumetric assessment. BJU Int. 2015 May;115(5):787-95. PubMed PMID: 24905965. 82. Zargar H, Samarasekera D, Khalifeh A, Remer EM, O'Malley C, et al. Laparoscopic vs percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urology. 2015 Apr;85(4):850-5. PubMed PMID: 25704992. 83. Autorino R, Zargar H, Butler S, Laydner H, Kaouk JH. Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the National Surgical Quality Improvement Program database. Urology. 2015 Apr;85(4):843-9. PubMed PMID: 25681252. 84. Abdi H, Zargar H, Goldenberg SL, Walshe T, Pourmalek F, et al. Multiparametric magnetic resonance imaging-targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results. Urol Oncol. 2015 Apr;33(4):165.e1-7. PubMed PMID: 25665509. 85. Larson JA, Kaouk JH, Stifelman MD, Rogers CG, Allaf ME, et al. Nonmodifiable factors and complications contribute to length of stay in robot-assisted partial nephrectomy. J Endourol. 2015 Apr;29(4):422-9. PubMed PMID: 25286232. 86. Zargar H, Akca O, Ramirez D, Brandao LF, Laydner H, et al. The impact of extended warm ischemia time on late renal function after robotic partial nephrectomy. J Endourol. 2015 Apr;29(4):444-8. PubMed PMID: 25203268. 87. Zargar H, Caputo P, Kaouk JH. Editorial comment. Urology. 2015 Mar;85(3):594-5. PubMed PMID: 25733271. 88. Ball MW, Gorin MA, Bhayani SB, Rogers CG, Stifelman MD, et al. Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis. Urol Oncol. 2015 Mar;33(3):112.e9-14. PubMed PMID: 25499258; NIHMSID: NIHMS642049; PubMed Central PMCID: PMC4380792. 89. Zargar H, Aning JJ, So AI. Surgery for treatment of metastatic testicular cancer. ANZ J Surg. 2015 Mar;85(3):189-90. PubMed PMID: 24171695.
12 90. Addison B, Zargar H, Lilic N, Merrilees D, Rice M. Analysis of 35 cases of Xanthogranulomatous pyelonephritis. ANZ J Surg. 2015 Mar;85(3):150-3. PubMed PMID: 24661744. 91. Haghdani S, Kafash Nayeri R, Zargar H, Zargar MA. Adrenocortical carcinoma with renal vein tumor thrombus extension. Urol J. 2015 Feb 22;12(1):2037-9. PubMed PMID: 25703915. 92. Abdi H, Pourmalek F, Zargar H, Walshe T, Harris AC, et al. Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer. Urology. 2015 Feb;85(2):423-8. PubMed PMID: 25623709. 93. Brandao L, Zargar H, Autorino R. Reply to Konstantinos P Economopoulos, Aliki Stamou, and Theodoros N Sergentanis' letter to the editor re: Luis Felipe Brandao, Riccardo Autorino, Humberto Laydner, et al Robotic versus laparoscopic adrenalectomy: a systematic review and meta-analysis Eur Urol 2014;65:1154-61. Eur Urol. 2015 Feb;67(2):e33-4. PubMed PMID: 25308969. 94. Zargar H, Coelho RF, Kaouk JH. Re: R Houston Thompson, Tom Atwell, Grant Schmit, et al Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses Eur Urol 2015;67:252-9. Eur Urol. 2015 Feb;67(2):e23. PubMed PMID: 25266972. 95. Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, et al. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2015 Feb;67(2):241-9. PubMed PMID: 25257030; NIHMSID: NIHMS774505; PubMed Central PMCID: PMC4840190. 96. Autorino R, Brandao LF, Sankari B, Zargar H, Laydner H, et al. Laparoendoscopic single-site (LESS) vs laparoscopic living-donor nephrectomy: a systematic review and meta-analysis. BJU Int. 2015 Feb;115(2):206-15. PubMed PMID: 24588876. 97. De S, Autorino R, Kim FJ, Zargar H, Laydner H, et al. Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis. Eur Urol. 2015 Jan;67(1):125-137. PubMed PMID: 25064687. 98. Laydner H, Akça O, Autorino R, Eyraud R, Zargar H, et al. Perineal robot-assisted laparoscopic radical prostatectomy: feasibility study in the cadaver model. J Endourol. 2014 Dec;28(12):1479-86. PubMed PMID: 25379638. 99. Vyas R, Zargar H, Trolio RD, Di Lorenzo G, Autorino R. Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks. World J Clin Cases. 2014 Nov 16;2(11):654-60. PubMed PMID: 25405188; PubMed Central PMCID: PMC4233419. 100. Zargar H, Khalifeh A, Autorino R, Akca O, Brandão LF, et al. Urine leak in minimally invasive partial nephrectomy: analysis of risk factors and role of intraoperative ureteral catheterization. Int Braz J Urol. 2014 Nov-Dec;40(6):763-71. PubMed PMID: 25615258.
13 101. Rahbar H, Bhayani S, Stifelman M, Kaouk J, Allaf M, et al. Evaluation of renal mass biopsy risk stratification algorithm for robotic partial nephrectomy--could a biopsy have guided management?. J Urol. 2014 Nov;192(5):1337-42. PubMed PMID: 24936720. 102. Brandao LF, Autorino R, Zargar H, Krishnan J, Laydner H, et al. Robot-assisted laparoscopic adrenalectomy: step-by-step technique and comparative outcomes. Eur Urol. 2014 Nov;66(5):898-905. PubMed PMID: 24830625. 103. Zargar H, Autorino R, Akca O, Kaouk JH. Anatomic complexity of renal masses and outcomes of minimally invasive partial nephrectomy: do we have an answer?. Eur Urol. 2014 Nov;66(5):894-6. PubMed PMID: 24709654. 104. Autorino R, Zargar H, White WM, Novara G, Annino F, et al. Current applications of near-infrared fluorescence imaging in robotic urologic surgery: a systematic review and critical analysis of the literature. Urology. 2014 Oct;84(4):751- 9. PubMed PMID: 25260441. 105. Zargar H, Bhayani S, Allaf ME, Stifelman M, Rogers C, et al. Comparison of perioperative outcomes of robot-assisted partial nephrectomy and open partial nephrectomy in patients with a solitary kidney. J Endourol. 2014 Oct;28(10):1224-30. PubMed PMID: 24959704. 106. Autorino R, Zargar H, Kaouk JH. Robotic-assisted laparoscopic surgery: recent advances in urology. Fertil Steril. 2014 Oct;102(4):939-49. PubMed PMID: 24993800. 107. Zargar H, Krishnan J, Autorino R, Akca O, Brandao LF, et al. Robotic nephroureterectomy: a simplified approach requiring no patient repositioning or robot redocking. Eur Urol. 2014 Oct;66(4):769-77. PubMed PMID: 24661639. 108. Kaouk JH, Samarasekera D, Krishnan J, Autorino R, Acka O, et al. Robotic partial nephrectomy with intracorporeal renal hypothermia using ice slush. Urology. 2014 Sep;84(3):712-8. PubMed PMID: 25168557. 109. Brandao LF, Zargar H, Autorino R, Akca O, Laydner H, et al. Robot-assisted partial nephrectomy for ≥ 7 cm renal masses: a comparative outcome analysis. Urology. 2014 Sep;84(3):602-8. PubMed PMID: 24929947. 110. Zargar H, Autorino R, Kaouk JH. Nephron-sparing surgery for tumors in a solitary kidney. Curr Opin Urol. 2014 Sep;24(5):459-65. PubMed PMID: 24921907. 111. Brandao LF, Zargar H, Laydner H, Akca O, Autorino R, et al. 30-day hospital readmission after robotic partial nephrectomy--are we prepared for Medicare readmission reduction program?. J Urol. 2014 Sep;192(3):677-81. PubMed PMID: 24530985. 112. Akca O, Zargar H, Autorino R, Brandao LF, Laydner H, et al. Robotic partial nephrectomy for caliceal diverticulum: a single-center case series. J Endourol. 2014 Aug;28(8):958-61. PubMed PMID: 24720868.
14 113. Zargar H, Kaouk JH, Akca O, Autorino R, Brandao LF, et al. Step-by-Step robotic heminephrectomy for duplicated renal collecting system. Int Braz J Urol. 2014 Jul-Aug;40(4):578-9. PubMed PMID: 25251965. 114. Zargar H, Kaouk JH. Robot-assisted nephrouretectomy: is LESS more?. BJU Int. 2014 Jul;114(1):7-8. PubMed PMID: 24964185. 115. Akca O, Zargar H, Autorino R, Brandao LF, Laydner H, et al. Robotic partial nephrectomy for cystic renal masses: a comparative analysis of a matched-paired cohort. Urology. 2014 Jul;84(1):93-8. PubMed PMID: 24821467. 116. Zargar H, Addison B, McCall J, Bartlett A, Buckley B, et al. Renal artery embolization prior to nephrectomy for locally advanced renal cell carcinoma. ANZ J Surg. 2014 Jul-Aug;84(7-8):564-7. PubMed PMID: 24548680. 117. Zargar H, Aning J, Legiehn G, Black P. Renovascular hypertension after laparoscopic partial nephrectomy. J Urol. 2014 May;191(5):1418-20. PubMed PMID: 24508453. 118. Brandao LF, Autorino R, Zargar H, Laydner H, Krishnan J, et al. Robotic ileal ureter: a completely intracorporeal technique. Urology. 2014 Apr;83(4):951-4. PubMed PMID: 24518286. 119. Zargar H, Aning J, Ischia J, So A, Black P. Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer. Nat Rev Urol. 2014 Apr;11(4):220- 30. PubMed PMID: 24619373. 120. Akca O, Zargar H, Stein R. Editorial comment. Urology. 2014 Mar;83(3):639; discussion 639-40. PubMed PMID: 24387930. 121. Zargar H, Stein RJ. Editorial comment for Ghani et al. J Endourol. 2013 Nov;27(11):1399. PubMed PMID: 23984678. 122. Zargar H, Anderson W, Koya M. Spontaneous intraperitoneal bladder rupture: a demanding diagnosis. ANZ J Surg. 2012 Jul-Aug;82(7-8):565-6. PubMed PMID: 22863231. 123. Omundsen M, Zargar H, Purchas S. Giant cyst: an underreported complication of hernia mesh repairs?. ANZ J Surg. 2008 Sep;78(9):822-3. PubMed PMID: 18844922. 124. Wickremesekera J, Farmillo W, Hawkins S, Zargar H, Choudhary A, et al. Endoluminal repair of abdominal aortic aneurysm: the Middlemore Hospital experience. N Z Med J. 2007 Mar 23;120(1251):U2467. PubMed PMID: 17384695. 125. Zargar MA, Shahrokh H, Mohammadi Fallah MR, Zargar H. Comparing Taguchi and anterior Lich-Gregoir ureterovesical reimplantation techniques for kidney transplantation. Transplant Proc. 2005 Sep;37(7):3077-8. PubMed PMID: 16213310.
15 126. Zargar MA, Darvishi A, Shadpour P, Shooshtari HZ. Hypoesthesia of the thigh following renal transplantation. Transplant Proc. 2003 Nov;35(7):2672. PubMed PMID: 14612066. 127. Kamali K, Zargar MA, Zargar H. Early common surgical complications in 1500 kidney transplantations. Transplant Proc. 2003 Nov;35(7):2655-6. PubMed PMID: 14612058.
Non-peer reviewed articles
Zargar h, Featured New SIU Members. SIU Newsletter. March 2016 Vol.12No1
Kaouk JH, Zargar h, Krishnan J. Intracorporeal hypothermia During Robotic Partial Nephrectomy Using Ice Slush. Urology & Kidney Disease News Vol. 24 Winter 2015
Zargar H, Ganesan V, Haber GP. Robotic Radical Cystectomy With Intracorporeal Urinary Diversion: A New Horizon. Urology & Kidney Disease News Vol. 24 Winter 2015
Zargar h, Kaouk JH. Robotic Partial Nephrectomy:” A New Era Of Trifecta”. European Urology today. Vol. 25 No.5 - October/November 2013
Invited Speaker/Faculty
Session chair. 71st USANZ ASM. February 2018, Melbourne, Australia Invited Faculty. 6th Techno-Urology Meeting (TUM): New technologies for a more precise surgery. January 2018, Turin, Italy Invited faculty. Philippines Society of Urology Oncology 6th annual convention Invited Speaker. Asia-Pacific Prostate Cancer Conference September 2017, Melbourne, Australia Invited faculty. ANZUP annual scientific meeting 2017, Melbourne, Australia Invited Speaker. Surgical Nutrition Symposium 2017, Melbourne, Australia Invited Speaker. Victorian Perioperative Nurses Group Conference 2017, Melbourne, Australia Invited Faculty. 5th Techno-Urology Meeting (TUM): tailoring the therapy that fits best. January 2017, Turin, Italy Negative messaging is having an impact in Australia – PSA testing and trends. Asia-Pacific Prostate Cancer Conference September 2016, Melbourne, Australia A prospective comparison of open, laparoscopic and radical prostatectomy, Asia- Pacific Prostate Cancer Conference September 2016, Melbourne, Australia
16 Current guidelines on the management of biochemical recurrence, Asia-Pacific Prostate Cancer Conference September 2016, Melbourne, Australia Invited faculty and course instructor. The 6TH Uro Oncology Update. February 2016, Jakarta,Indonesia Multi-tumour syndromes – evaluation and management. 4th National Bladder and Kidney Cancer Symposium. February 2016, Melbourne, Australia Imaging-based volumetric assessment in nephron sparing surgery: a new paradigm? 4th Techno-Urology Meeting (TUM): from preclinical setting to the operating room. January 2016, Turin Italy Invited Faculty. 4th Techno-Urology Meeting (TUM): from preclinical setting to the operating room. January 2016, Turin Italy Robotic-Assisted Inguinal Lymphadenectomy. SIU 2015 Melbourne, Australia MP-18: Kidney & Ureteral Cancer. SIU 2015 Melbourne, Australia. Session’s chair Bladder Cancer Care Pathway. 6th International Symposium on Robotic Urologic Surgery. Cleveland Clinic 2014 Presentations:
Dose Dense MVAC Prior To Radical Cystectomy: A Retrospective Multi- Institutional Experience. USANZ 2017 Canberra, Australia Planning and implementation of an Enhanced Recovery After Surgery (ERAS) program for radical cystectomy in a major metropolitan hospital by specialist advanced practice. USANZ 2017 Canberra, Australia Cryoablation versus partial nephrectomy for clinical t1b tumors: a matched group analysis. USANZ 2017 Canberra, Australia Partial Nephrectomy Vs. Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. USANZ 2017 Canberra, Australia Cryoablation versus partial nephrectomy for clinical t1b tumors: a matched group analysis. AUA 2016 San Diego, Ca. Outcomes and safety profile of transperineal prostate biopsy: results from the Victorian transperineal biopsy collaboration. AUA 2016 San Diego, Ca. Race effects on pathological and functional outcomes after robotic partial nephrectomy. AUA 2016 San Diego, Ca. Early experience of robotic salvage pelvic lymph node dissection in the ga-68 PSMA PET scanning era. AUA 2016 San Diego, Ca. Validation of the novel 5-group Gleason grading system: 3+5 disease risk may be overestimated. AUA 2016 San Diego, Ca. Partial nephrectomy versus radical nephrectomy for clinical t1b and t2 renal mass: a meta-analysis of over 9000 cases. AUA 2016 San Diego, Ca. Sarcomatoid and rhabdoid differentiation have similar prognostic effects for patients with grade 4 renal cell carcinoma? AUA 2016 San Diego, Ca. The impact of United States preventive services task force (USPTSTF) recommendation on PSA testing in Australia. AUA 2016 San Diego, Ca.
17 Descriptive technique for robotic radical perineal prostatectomy combined with extended pelvic lymph node dissection. AUA 2016 San Diego, Ca. Prospective longitudinal comparative study of long-term urinary and sexual function after primary surgical treatment for localized prostate cancer. AUA 2016 San Diego, Ca. Prospective longitudinal comparative study of long-term urinary and sexual function after primary surgical treatment for localised prostate cancer. USANZ 2016 Gold Coast, Australia Outcomes and safety profile of transperineal prostate biopsy: results from the Victorian transperineal biopsy collaboration. USANZ 2016 Gold Coast, Australia Perioperative outcomes of men treated with robotic prostatectomy and extended lymph node dissection. USANZ 2016 Gold Coast, Australia Oncological outcomes of men with ductal and intraductal prostate cancer treated with prostatectomy: a single centre analysis. USANZ 2016 Gold Coast, Australia The impact of United States Preventive Services Task Force (USPTSTF) recommendation on PSA testing in Australia. USANZ 2016 Gold Coast, Australia Assessment of the impact of renal mass biopsy on the perioperative outcomes of robotic assisted partial nephrectomy. USANZ 2016 Gold Coast, Australia Early experience of robotic salvage pelvic lymph node dissection in the Ga-68 PSMA PET scanning era. EAU 2016 Munich, Germany Technique and outcomes of transperineal prostate biopsy: The Victorian Transperineal Biopsy Collaboration. EAU 2016 Munich, Germany Validation of the novel 5-group Gleason grading system: 3+5 disease risk may be overestimated. EAU 2016 Munich, Germany Assessment of Psoas Muscle Volume Loss as Predictor of Response and Outcomes after Neoadjuvant Chemotherapy and Radical Cystectomy in Muscle- Invasive Bladder Cancer. SIU 2015 Melbourne, Australia Final Pathologic Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer: Does pT0 Predict Better Survival than pTa/pTis/pT1? SIU 2015 Melbourne, Australia Five-Year Oncological Outcomes after Robotic Partial Nephrectomy for Renal Cell Carcinomas. SIU 2015 Melbourne, Australia Management of Challenging Urethra- Ileal Anastomosis during Robotic Intracorporeal Neobladder Formation. SIU 2015 Melbourne, Australia Robotic Pyelolithotomy at the Time of Partial Nephrectomy. SIU 2015 Melbourne, Australia Achievement of Trifecta in Minimally Invasive Partial Nephrectomy Correlates with Functional Preservation of Operated Kidney: A Multi-Institutional Assessment Using MAG3 Renal Scan. SIU 2015 Melbourne, Australia Step-By-Step Robotic Ureteroureterostomy: Tips And Tricks To Optimize Outcomes. AUA 2015 New Orleans, LA Minimum 5-Year Follow-Up After Robotic Partial Nephrectomy: A Multi- Institutional Analysis. AUA 2015 New Orleans, LA Catabolic Effects Of Surgical Approaches Measured By Weight Change In Patients Undergoing Partial Nephrectomy. AUA 2015 New Orleans, LA
18 Racial Differences In Histologic Subtype Of Renal Cell Carcinoma In Pt1a Renal Cell Cancer. AUA 2015 New Orleans, LA Radical Cystectomy Practices Among Uro-Oncologists: A State Of The Art Survey. AUA 2015 New Orleans, LA Evaluation Of De Novo Hypertension After Robotic Partial Nephrectomy: A Single Center Analyses. AUA 2015 New Orleans, LA Complications After Robotic-Assisted Partial Nephrectomy At 5 United States Centers: Analysis Of 1838 Cases. AUA 2015 New Orleans, LA Robotic Partial Nephrectomy With Intracorporeal Renal Hypothermia Using Ice Slush. AUA 2015 New Orleans, LA Tumor Size Predicts High-Grade Pathology In Pt1a Renal Cell Cancer. AUA 2015 New Orleans, LA Robotic Anterior Pelvic Exenteration With Intracorporeal Ileal Conduit In A Patient With History Of Kidney Pancreas Transplantation. AUA 2015 New Orleans, LA Management Of Challenging Urethro-Ileal Anastomosis During Robotic Intracorporeal Neobladder Formation. AUA 2015 New Orleans, LA Perineal Robot Assisted Laparoscopic Radical Prostatectomy (P-RALP). AUA 2015 New Orleans, LA The Effects Of Non-Neoplastic Renal Parenchymal Abnormalities On Renal Functional Outcomes After Partial Nephrectomy. AUA 2015 New Orleans, LA A Multi-Institutional Analysis Of Outcomes In Patients With Clinically Node Positive Urothelial Bladder Cancer Treated With Induction Chemotherapy And Radical Cystectomy. AUA 2015 New Orleans, LA Incidence Of Major Complications For Laparoscopic Radical And Robotic Partial Nephrectomy: A Match-Paired Analysis. AUA 2015 New Orleans, LA The Interval Between Diagnosis And Radical Cystectomy Does Not Impact The Outcomes Of Patients Treated With Neoadjuvant Chemotherapy. AUA 2015 New Orleans, LA Final Pathologic Stage After Neoadjuvant Chemotherapy And Radical Cystectomy For Bladder Cancer: Does pT0 Predict Better Survival Than pTa/pTis/pT1? AUA 2015 New Orleans, LA Trifecta Outcomes Of Robotic Partial Nephrectomy For T1b Renal Masses: A Multi-Institutional Analysis. AUA 2015 New Orleans, LA Robot assisted perineal radical prostatectomy in the setting of previous AP excision of rectum.EAU 2015 Madrid,Spain Final pathologic stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Does pT0 predict better survival than pTa/pTis/pT1?.EAU 2015 Madrid,Spain A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.EAU 2015 Madrid,Spain Nomogram predicting cancer specific mortality (CSM) after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (BC): Results of an international consortium. EAU 2015 Madrid,Spain
19 The interval between diagnosis and radical cystectomy does not impact the outcomes of patients treated with neoadjuvant chemotherapy. EAU 2015 Madrid,Spain Robotic Pyelolithotomy And Ureteropelvic Junction Repair In A Cross Fused Ectopic Kidney. AUA 2014 Orlando, FL Active Surveillance In 853 Men With Low And Intermediate Risk Prostate Cancer. AUA 2014 Orlando, FL Step-By-Step Technique Of Robot-Assisted Radical Cystectomy At Cleveland Clinic. AUA 2014 Orlando, FL The Effects Of Prolonged Warm Ischemia On Late Renal Function After Robotic Partial Nephrectomy. AUA 2014 Orlando, FL Does Multiple Vessel Clamping Affect The Surgical And Funcional Outcomes In Robotic Partial Nephrectomy? AUA 2014 Orlando, FL Robotic-Assisted Laparoscopic Partial Nephrectomy With Intracorporeal Cooling For A Renal Mass. AUA 2014 Orlando, FL Objective Assessment Of Preservation Of Gfr After Robotic Partial Nephrectomy Using Mercapto-Acetyltriglycine (Mag 3) Renal Scan. AUA 2014 Orlando, FL Comparison Of Peri-Operative Outcomes Of Robotic Partial Nephrectomy And Open Partial Nephrectomy In Patients With Solitary Kidneys. AUA 2014 Orlando, FL Comparison Of Pathological And Oncological Outcomes Of Men On Active Surveillance Progressing To Radical Prostatectomy With A Matched Cohort Of Men Undergoing Immediate Radical Prostatectomy In A Single Institution. AUA 2014 Orlando, FL Robotic Retroperitoneal Lymph Node Dissection For Stage 1 Non-Seminomatous Testicular Cancer: Technically Feasible With Left And Right Modified Templates. AUA 2014 Orlando, FL Possible Complications During Robotic Cystectomy And How To Avoid Them. AUA 2014 Orlando, FL Trifecta Of Outcomes In 1800 Cases Of Laparoscopic And Robotic Partial Nephrectomy: A Multi-Institutional Review. AUA 2014 Orlando, FL Risk Factors For 30-Day Hospital Readmission Of Robotic Partial Nephrectomy Patients. AUA 2014 Orlando, FL Multi-Parametric Mri Enhances Detection Of Significant Tumor In Patients On Active Surveillance For Prostate Cancer. AUA 2014 Orlando, FL Unclamped Robotic Assisted Laparoscopic Partial Nephrectomy: Demonstration Of The Sequential Preplaced Suture Technique. AUA 2014 Orlando, FL Validation Of AUA Clinical Practice Guidelines For Followup Of Kidney Cancer After Robotic Partial Nephrectomy. AUA 2014 Orlando, FL Preoperative Predictors Of Malignancy And Unfavorable Pathology For Clinical T1a Renal Tumors Treated With Partial Nephrectomy. AUA 2014 Orlando, FL Pathologic Response To Neoadjuvant Chemotherapy In A Multicentre Cohort Of Patients With Muscle Invasive Bladder Cancer. AUA 2014 Orlando, FL Robot-Assisted Adrenalectomy: Tips, Tricks And Surgical Technique. AUA 2014 Orlando, FL
20 MRI Targeted Biopsy For The Detection Of Prostate Cancer In Patients After Prior Negative Biopsies. AUA 2014 Orlando, FL Comparison of peri-operative outcomes of robotic partial nephrectomy and laparoscopic partial nephrectomy in surgical treatment of small renal masses. 29th annual EAU congress, Stockholm 2014. The role of multi-parametric MRI in the management of patients on active surveillance for prostate cancer. 29th annual EAU congress, Stockholm 2014
Active surveillance in 853 men with low and intermediate risk prostate cancer. 29th annual EAU congress, Stockholm 2014 Comparing the trifecta of outcomes in 1800 cases of laparoscopic and robotic partial nephrectomy. Urological Society of Australia and New Zealand 67th Annual Scientific Meeting, Brisbane, Australia, March 2014 Comparison of pathological and oncological outcomes of men on active surveillance progressing to radical prostatectomy with a matched cohort of men undergoing immediate radical prostatectomy in a single institution. Urological Society of Australia and New Zealand 67th Annual Scientific Meeting, Brisbane, Australia, March 2014 Objective assessment of preservation of GFR after robotic partial nephrectomy using mercapto-acetyltriglycine (MAG 3) renal scan. Urological Society of Australia and New Zealand 67th Annual Scientific Meeting, Brisbane, Australia, March 2014 The effects of prolonged warm ischemia on late renal function after robotic partial nephrectomy. Urological Society of Australia and New Zealand 67th Annual Scientific Meeting, Brisbane, Australia, March 2014 Multicentre Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. 33st Congress of the SIU, Vancouver 2013. Neoadjuvant chemotherapy for muscle invasive bladder cancer: a multi- institutional evaluation of pathologic response. 92nd Annual Meeting of the South Central Section of the AUA Chicago, IL , Sept 2013. Metastatic Teratoma. Shelby Webster Testis Cancer Meeting, Settle, WA, Jan 2013 Ureteroscopy in the acute management of ureteric stones: retrospective study of a one-year experience. Urological Society of Australia and New Zealand 65th Annual Scientific Meeting, Darwin, Australia, April 2012 Renal artery embolization prior to radical nephrectomy; a retrospective analysis of 42 cases. Urological Society of Australia and New Zealand 65th Annual Scientific Meeting, Darwin, Australia, April 2012 Topical Diltiazem before transrectal ultrasonography (TRUS)-guided biopsy of the prostate: A randomised controlled trial. 31st Congress of the SIU-ICC Berlin 2011. Embolization prior to nephrectomy: Auckland Hospital experience, Urological Society of Australia & New Zealand- NZ Section Meeting- Hamilton 2011.
21 Topical Diltiazem before transrectal ultrasonography (TRUS)-guided biopsy of the prostate: A randomised controlled trial. Urological Society of Australia & New Zealand - NZ Section Meeting -Nelson 2010. Topical Diltiazem before transrectal ultrasonography (TRUS)-guided biopsy of the prostate: A randomised controlled trial. Urological Society of Australasia Annual Scientific Meeting, Perth 2009. In-vivo evaluation of pressure/flow Characteristics of resonance ureteral stents, Urological Society of Australia & New Zealand - NZ Section Meeting- Napier 2009. An audit of the surgical management of breast cancer at Hutt Hospital. New Zealand Association of General Surgeons Annual Meeting, Bay of Islands 2008 Hutt Valley colorectal audit. New Zealand Association of General Surgeons Annual Meeting, Bay of Islands 2008 Mismatch repair protein expression in ovine intestinal adenocarcinomas. New Zealand Association of General Surgeons Annual Meeting, Bay of Islands 2008 An audit of the surgical management of breast cancer at Hutt Hospital. Royal Australasian College of Surgeons and The College of Surgeons of Hong Kong Conjoint Annual Scientific Congress, Hong Kong 2008 Hutt Valley colorectal audit. Royal Australasian College of Surgeons and The College of Surgeons of Hong Kong Conjoint Annual Scientific Congress, Hong Kong 2008 A randomized controlled trial comparing efficacy and acceptability of Fleet® with Picoprep® in preparation for colonoscopy. Royal Australasian College of Surgeons and The College of Surgeons of Hong Kong Conjoint Annual Scientific Congress, Hong Kong 2008 Bench surgery in solitary kidney with renal cell carcinoma. Iranian Urology Association Annual Congress, Tehran 2008 Audit of androgen Deprivation Therapy (ADT) register in Auckland region. Urological Society of Australasia Annual Scientific Meeting, Brisbane 2006 Medical treatment of patients with oligospermia associated with varicocele. Royal Australasian College of Surgeons NZ Annual Scientific Congress, Hamilton 2005 Comparison of surgical and medical treatment of patients with left Varicocele associated with Oligoasthenospermia. Iranian Urological Association Annual Congress, Tehran 2005
22